Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

huN901-DM1

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
2146 IMGN901 (huN901-DM1) is an antibody-maytansinoid conjugate which targets CD56 and is being evaluated as a single agent in… Expand
Is this relevant?
2008
2008
patient. The gaps in therapy for Patient 3 were produced by attempts to discontinue decitabine then darbopoietin when haemoglobin… Expand
Is this relevant?
2007
2007
18084 Background: HuN901-DM1, a humanized antibody-maytansinoid immunoconjugagte, binds to CD56 which is expressed in almost all… Expand
Is this relevant?
2007
2007
Background: huN901-DM1 (BB-10901) is a humanized monoclonal antibody that binds with high affinity to CD56 and is covalently… Expand
Is this relevant?
2006
2006
Background: BB-10901 is a humanized monoclonal antibody that binds with high affinity to CD56 and is covalently linked to a novel… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Immunoconjugates are being explored as novel cancer therapies with the promise of target‐specific drug delivery. The… Expand
Is this relevant?
2005
2005
  • S. Smith
  • Current opinion in molecular therapeutics
  • 2005
  • Corpus ID: 7706870
ImmunoGen is developing huN901-DMI, a compound comprised of a CD56-targeted humanized N901 antibody conjugated to the company's… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
HuN901 is a humanized monoclonal antibody that binds with high affinity to CD56, the neuronal cell adhesion molecule. HuN901… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?